标题 |
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers
FHD-286的发现,一种用于治疗开关/蔗糖不可发酵(SWI/SNF)依赖性癌症的Brahma同源物(BRM)和Brahma相关基因1(BRG1)ATP酶活性的首个口服生物利用度变构双重抑制剂
|
网址 | |
DOI | |
其它 |
期刊:Journal of Medicinal Chemistry 作者:Rishi G. Vaswani; David S. Huang; Neville Anthony; Lan Xu; Richard Centore; et al 出版日期:2025 |
求助人 | |
下载 | 求助已完成,仅限求助人下载。 |